WO2022262996A1 - Verfahren zur herstellung von polysaccharidsulfaten und polysaccharidsulfat - Google Patents
Verfahren zur herstellung von polysaccharidsulfaten und polysaccharidsulfat Download PDFInfo
- Publication number
- WO2022262996A1 WO2022262996A1 PCT/EP2021/066640 EP2021066640W WO2022262996A1 WO 2022262996 A1 WO2022262996 A1 WO 2022262996A1 EP 2021066640 W EP2021066640 W EP 2021066640W WO 2022262996 A1 WO2022262996 A1 WO 2022262996A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polysaccharide
- sulfate
- mixture
- cellulose
- produced
- Prior art date
Links
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 146
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 146
- -1 polysaccharide sulfates Chemical class 0.000 title claims abstract description 123
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 34
- 239000000203 mixture Substances 0.000 claims abstract description 65
- 238000000034 method Methods 0.000 claims abstract description 64
- 239000003094 microcapsule Substances 0.000 claims abstract description 40
- 150000004676 glycans Chemical class 0.000 claims abstract description 38
- 125000005385 peroxodisulfate group Chemical group 0.000 claims abstract description 20
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 17
- 239000003880 polar aprotic solvent Substances 0.000 claims abstract description 10
- 229920002678 cellulose Polymers 0.000 claims description 80
- 239000001913 cellulose Substances 0.000 claims description 80
- 235000010980 cellulose Nutrition 0.000 claims description 80
- 238000006467 substitution reaction Methods 0.000 claims description 74
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 61
- 239000008186 active pharmaceutical agent Substances 0.000 claims description 44
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 claims description 33
- 239000000463 material Substances 0.000 claims description 27
- 239000000243 solution Substances 0.000 claims description 27
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 20
- 239000007864 aqueous solution Substances 0.000 claims description 19
- 239000000725 suspension Substances 0.000 claims description 19
- 229920006317 cationic polymer Polymers 0.000 claims description 16
- 238000005670 sulfation reaction Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 230000019635 sulfation Effects 0.000 claims description 14
- 238000001556 precipitation Methods 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 13
- 230000001180 sulfating effect Effects 0.000 claims description 13
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical group CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000012345 acetylating agent Substances 0.000 claims description 10
- KEQGZUUPPQEDPF-UHFFFAOYSA-N 1,3-dichloro-5,5-dimethylimidazolidine-2,4-dione Chemical compound CC1(C)N(Cl)C(=O)N(Cl)C1=O KEQGZUUPPQEDPF-UHFFFAOYSA-N 0.000 claims description 8
- XTHPWXDJESJLNJ-UHFFFAOYSA-N chlorosulfonic acid Substances OS(Cl)(=O)=O XTHPWXDJESJLNJ-UHFFFAOYSA-N 0.000 claims description 8
- 229920000867 polyelectrolyte Polymers 0.000 claims description 8
- 229920001661 Chitosan Polymers 0.000 claims description 6
- 229910021653 sulphate ion Inorganic materials 0.000 claims description 6
- 238000005406 washing Methods 0.000 claims description 6
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 4
- 125000002091 cationic group Chemical group 0.000 claims description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
- 238000002513 implantation Methods 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 claims description 4
- 125000003158 alcohol group Chemical group 0.000 claims description 3
- 239000012670 alkaline solution Substances 0.000 claims description 3
- 238000003776 cleavage reaction Methods 0.000 claims description 3
- 230000008030 elimination Effects 0.000 claims description 3
- 238000003379 elimination reaction Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 230000007017 scission Effects 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 2
- 229920000896 Ethulose Polymers 0.000 claims description 2
- 239000001859 Ethyl hydroxyethyl cellulose Substances 0.000 claims description 2
- 229920002488 Hemicellulose Polymers 0.000 claims description 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 2
- 229920001479 Hydroxyethyl methyl cellulose Polymers 0.000 claims description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 claims description 2
- 239000012346 acetyl chloride Substances 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 claims description 2
- 239000012935 ammoniumperoxodisulfate Substances 0.000 claims description 2
- 150000004651 carbonic acid esters Chemical class 0.000 claims description 2
- 239000012876 carrier material Substances 0.000 claims description 2
- IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 claims description 2
- 235000019326 ethyl hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 2
- 150000003951 lactams Chemical class 0.000 claims description 2
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 claims description 2
- 229920000724 poly(L-arginine) polymer Polymers 0.000 claims description 2
- 108010011110 polyarginine Proteins 0.000 claims description 2
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 claims description 2
- 230000001376 precipitating effect Effects 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 229940063675 spermine Drugs 0.000 claims description 2
- 150000003462 sulfoxides Chemical class 0.000 claims description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 claims description 2
- 150000003860 tertiary carboxamides Chemical class 0.000 claims description 2
- 229940126601 medicinal product Drugs 0.000 claims 1
- 125000001273 sulfonato group Chemical class [O-]S(*)(=O)=O 0.000 claims 1
- 230000021736 acetylation Effects 0.000 abstract 1
- 238000006640 acetylation reaction Methods 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 50
- 229920000642 polymer Polymers 0.000 description 24
- 230000015572 biosynthetic process Effects 0.000 description 20
- 238000003786 synthesis reaction Methods 0.000 description 19
- 125000001424 substituent group Chemical group 0.000 description 18
- 238000009826 distribution Methods 0.000 description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 15
- 229910052717 sulfur Inorganic materials 0.000 description 15
- 239000011593 sulfur Substances 0.000 description 15
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 14
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 12
- 238000000921 elemental analysis Methods 0.000 description 10
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- 229920002301 cellulose acetate Polymers 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- 229910052799 carbon Inorganic materials 0.000 description 6
- 230000015556 catabolic process Effects 0.000 description 6
- 238000006731 degradation reaction Methods 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 238000010626 work up procedure Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 description 4
- 229920000617 arabinoxylan Polymers 0.000 description 4
- 239000002608 ionic liquid Substances 0.000 description 4
- TWNIBLMWSKIRAT-VFUOTHLCSA-N levoglucosan Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@H]2CO[C@@H]1O2 TWNIBLMWSKIRAT-VFUOTHLCSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000012429 reaction media Substances 0.000 description 4
- PZAGQUOSOTUKEC-UHFFFAOYSA-N acetic acid;sulfuric acid Chemical compound CC(O)=O.OS(O)(=O)=O PZAGQUOSOTUKEC-UHFFFAOYSA-N 0.000 description 3
- 239000000010 aprotic solvent Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 150000004804 polysaccharides Polymers 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical group N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 229910002567 K2S2O8 Inorganic materials 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000006386 neutralization reaction Methods 0.000 description 2
- 235000019394 potassium persulphate Nutrition 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Inorganic materials O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 244000166124 Eucalyptus globulus Species 0.000 description 1
- 241000294754 Macroptilium atropurpureum Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 238000001069 Raman spectroscopy Methods 0.000 description 1
- WSNZLQGGHKYFAZ-UHFFFAOYSA-M [Na+].[O-]S(Cl)(=O)=O Chemical compound [Na+].[O-]S(Cl)(=O)=O WSNZLQGGHKYFAZ-UHFFFAOYSA-M 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 150000003868 ammonium compounds Chemical class 0.000 description 1
- 235000019568 aromas Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-QRZGKKJRSA-N beta-cellobiose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QRZGKKJRSA-N 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 238000006897 homolysis reaction Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012907 medicinal substance Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Chemical group 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 150000004976 peroxydisulfates Chemical class 0.000 description 1
- JRKICGRDRMAZLK-UHFFFAOYSA-N peroxydisulfuric acid Chemical class OS(=O)(=O)OOS(O)(=O)=O JRKICGRDRMAZLK-UHFFFAOYSA-N 0.000 description 1
- 229920000371 poly(diallyldimethylammonium chloride) polymer Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000005067 remediation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 150000003470 sulfuric acid monoesters Chemical class 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B5/00—Preparation of cellulose esters of inorganic acids, e.g. phosphates
- C08B5/14—Cellulose sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/14—Polymerisation; cross-linking
Definitions
- the present invention relates to a process for preparing polysaccharide sulfates.
- a mixture comprising at least one
- the at least one polysaccharide is converted into at least one polysaccharide acetate sulfate by adding at least one sulfating agent, at least one acetylating agent and at least one peroxodisulfate to the mixture and then subjecting the mixture to a temperature treatment.
- the at least one polysaccharide acetate sulfate is separated from the mixture and converted into at least one polysaccharide sulfate.
- the present invention also relates to a polysaccharide sulphate which can be produced using the method according to the invention. Furthermore, the present invention also relates to a microcapsule and a
- Sodium cellulose sulphate is a water-soluble poly mer of sulfuric acid monoester of cellulose that has been known for a long time. With the help of an aqueous solution of sodium cellulose sulfate Lö can by dropping into an aqueous solution of cationic polymers such.
- Sodium cellulose sulfate can be formed by esterifying the hydroxy groups of cellulose with a sulfating agent such as sulfuric anhydride, sulfuric acid, or derivatives thereof, and then converting the acidic half-ester to a neutral sodium salt.
- a sulfating agent such as sulfuric anhydride, sulfuric acid, or derivatives thereof
- Lucanoff et al. (Lukanoff, B. and Dautzenberg, H., Das Textil, 1994, 6, 287-298) further developed a known heterogeneous production process (US Pat. No. 2,539,451/US Pat. No. 2,969,355) using sulfuric acid and propanol as the reaction medium and sulfating agent.
- a heterogeneous production process e.g. according to Bohlmann et al. (Chemie Ingenieurtechnik, 2021, 74, 359-363)
- the reaction medium is first prepared from 96% strength sulfuric acid and isopropanol in a molar ratio of 1.8:1.
- the sulfation of the cellulose takes place at ⁇ 5° C. over a period of 150 minutes.
- the reaction mixture is separated from the cellulose sulfuric acid semiester formed with alcohol and washed out.
- the washed product is then converted into the sodium salt with sodium hydroxide solution.
- Another serious disadvantage of the heterogeneous manufacturing process is the rapid and severe chain length degradation of the cellulose during the progressive sulfation.
- the sulfation reaction e.g. B. by washing steps that dissipate sufficient heat and thus avoid a further rise in temperature, aborted.
- diffusion and swelling processes as well as the morphological structure of the cellulose have a significant influence on the course of the reaction, since the reaction as a whole takes place while maintaining a solid structure of the cellulose.
- DE 4019116 A1 proposes preactivation of the cellulose, although only very low-viscosity products with a maximum of 8.5 mPas in l % aqueous solution can be obtained.
- these cellulose sulfates are used to produce Symplex microcapsules, it can be observed that only microcapsules with very low mechanical strength are formed.
- higher-viscosity cellulose sulfates can be isolated from the resulting reaction product by separating the water-insoluble components in additional process steps and washing out the soluble but too low-viscosity components (cf. Lukanoff, B. and Dautzenberg, H., Das Textil, 1994 , 6, 287-298).
- an intermediate cellulose derivative that is soluble in organic solvents is usually used, which can better suppress the chain length degradation of cellulose during the sulfation reaction. Because the sulfation after or under more complete If the solid structure is dissolved in a dipolar aprotic solvent, a more uniform distribution of substituents is achieved. The end product has a higher solution viscosity and in some cases is completely water-soluble even at DS values of 0.25.
- ionic liquids such as l-ethyl-3-methylimidazolium acetate (EMIMAc) or l-butyl-3-methylimidazolium chloride (BMIMCI). Due to the high viscosity, the invention makes it necessary to add co-solvents such as N,N-dimethylformamide (DMF). In addition to this increased preparation effort, the use of ionic liquids is a disadvantage. Because ionic liquids are used, cellulose sulfates can only be used for medical and pharmaceutical applications after a complex purification process. In addition, the use of ionic liquids on an industrial scale is currently limited by their high production costs.
- ionic liquids such as l-ethyl-3-methylimidazolium acetate (EMIMAc) or l-butyl-3-methylimidazolium chloride (BMIMCI). Due to the high viscosity, the invention makes it necessary to add co-solvents such as N,N-dimethylformamide (DM
- a process for the production of polysaccharide sulfates in which a) a mixture comprising at least one polysaccharide and at least one polar aprotic solvent is produced, b) the at least one polysaccharide is converted into at least one polysaccharide acetate sulfate by at least one sulfating agent, at least one acetylating agent and at least one peroxodisulfate are added to the mixture and the mixture is then subjected to a temperature treatment, c) the at least one polysaccharide acetate sulfate is separated from the mixture, and d) the at least one polysaccharide acetate sulfate is converted into at least one polysaccharide sulfate
- a mixture is first prepared which comprises at least one polysaccharide, such as cellulose, and at least one polar aprotic solvent, such as dimethylformamide.
- the mixture can be a dispersion.
- the mixture can be produced by dispersing the at least one polysaccharide in the at least one polar aprotic solvent.
- the at least one polysaccharide is converted into at least one polysaccharide acetate sulfate by adding at least one sulfating agent, at least one acetylating agent and at least one peroxodisulfate to the mixture (produced in step a) and then subjecting the mixture to a temperature treatment.
- the at least one sulfating agent and the at least one acetylating agent are first added to the mixture and then the at least one peroxodisulfate is added to the mixture.
- the temperature treatment can be, for example, at a temperature in the range of -10 °C to 150 °C for a period of 1 min to 30 h.
- the at least one polysaccharide acetate sulfate can be dissolved in the mixture.
- step c) the at least one polysaccharide acetate sulfate (produced in step b) is separated from the mixture.
- a precipitation medium e.g. containing at least one alcohol and water
- separating the at least one polysaccharide acetate sulfate that has precipitated out by a mechanical separation process e.g. by filtration (from the Mixture and the precipitation medium) is separated.
- step d) the at least one polysaccharide acetate sulfate is converted into at least one polysaccharide sulfate. This can be done, for example, by alkaline elimination of the acetate groups.
- polysaccharide sulfates can be produced which are particularly suitable for the production of microcapsules, in particular for the production of microcapsules by drop formation, in which the shell is a polyelectrolyte complex made from a cationic polymer, such as poly(DADMAC), and the includes polysaccharide sulfate.
- a material to be encapsulated such as a pharmaceutically active substance, can be encapsulated in such microcapsules.
- microcapsules can be used, for example, as medicines, in implantation processes and in injection processes.
- the process according to the invention is characterized in particular by the use of at least one peroxodisulfate.
- peroxodisulfate during the acetosulfation of polysaccharides significantly increases the degree of substitution and thus improves the solubility of the polysaccharide sulfate produced in water, while at the same time the use of strong sulfating agents, such as chlorosulfonic acid, can be significantly reduced .
- This is also advantageous because the use of strong sulfating agents, particularly large proportions thereof, can lead to degradation of the polysaccharide chain.
- the polysaccharide sulfate produced by the process according to the invention is particularly suitable for the production of microcapsules.
- sulfates such as K 2 SO 4 or Na 2 SC> 4 (instead of the peroxodisulfates), however, these advantages cannot be achieved.
- Peroxodisulfates are salts of peroxodisulfuric acid, which are used industrially as bleaching and oxidizing agents but also to initiate the polymerization of various alkenes, including styrene, acrylonitrile and fluoroalkenes. The polymerisation is initiated by the homolysis of the peroxodisulphate. It is also known that sodium peroxodisulphate can be used for soil and groundwater remediation, for water and waste water treatment and for etching copper on printed circuit boards. Commonly used peroxydisulfates are potassium and ammonium compounds.
- a so-called polysaccharide acetate sulphate e.g. cellulose acetate sulphate
- this mixed ester is soluble in aprotic solvents such as DMF.
- the synthesis used in the method according to the invention is a quasi-homogeneous synthesis, which means that during the synthesis the polysaccharide is dissolved in the solvent by modifying the polysaccharide to form a derivative which, in contrast to the polysaccharide in the solvent is soluble.
- the solubility of the polysaccharide acetate sulphate leads to a homogeneous distribution of the substituents along the polymer chain. Such a homogeneous distribution is helpful in dissolving processes.
- a polysaccharide sulfate obtained by means of quasi-homogeneous synthesis has improved solubility due to the homogeneous distribution of substituents.
- Such a product could then have an overall degree of substitution DS of, for example, 0.7, but at the same time have areas where the DS is significantly higher and other areas where the DS is significantly lower. Consequently, such products have significantly poorer properties, such. B. poor solubility in water and are therefore less suitable for the production of microcapsules.
- the polysaccharide sulfates produced using the process according to the invention have a high degree of substitution, a homogeneous distribution of substituents and an advantageous regioselective distribution of substituents (within an AGU or anhydromonosaccharide unit) due to the special preparation.
- These advantageous properties lead to very good solubility of the polysaccharide sulfate produced in water, which is why the polysaccharide sulfates produced using the process according to the invention are particularly suitable for the production of microcapsules.
- a preferred variant of the method according to the invention is characterized in that the at least one polysaccharide is selected from the group consisting of cellulose, hemicellulose, chitosan, hyaluronic acid, hydroxyethyl cellulose, hydroxypropyl cellulose, methyl hydroxyethyl cellulose, methyl hydroxypropyl cellulose, methyl hydroxybutyl cellulose, ethyl hydroxyethyl cellulose, carboxymethyl hydroxyethyl cellulose and mixtures thereof .
- the at least one polysaccharide is particularly preferably cellulose.
- the at least one polar aprotic solvent is selected from the group consisting of tertiary carboxamides, e.g. dimethylformamide,
- carbonic acid esters e.g. dimethyl carbonate
- sulfoxides e.g. dimethyl sulfoxide
- lactams e.g., N-methyl-2-pyrrolidone, and mixtures thereof.
- a further preferred variant of the method according to the invention is characterized in that the mixture in step a) is produced in that the at least one polysaccharide in the at least one polar ren aprotic solvent is dispersed.
- the mixture (or dispersion) obtained in this way is preferably heated before step b) at a temperature in the range from 10° C. to 150° C., preferably from 50° C. to 120° C., and/or for a period of 1 min stirred for 10 hours, preferably from 30 minutes to 5 hours.
- the at least one sulfating agent is selected from the group consisting of sulfuric acid, chlorosulfonic acid, SC>3 complexes, sulfamic acid, sulfuryl chloride, and mixtures thereof
- the at least an acetylating agent is selected from the group consisting of acetic anhydride, acetyl chloride, and mixtures thereof
- the at least one peroxodisulfate is selected from the group consisting of potassium peroxodisulfate, ammonium peroxodisulfate, sodium peroxodisulfate, and mixtures thereof.
- the mixture produced in step a) contains a maximum of 3 mol/mol AGU (or anhydromonosaccharide unit), preferably a maximum of 2 mol/mol AGU (or anhydromonosaccharide unit), particularly preferably a maximum of 1 mol/mol AGU (or anhydromonosaccharide unit), particularly preferably a maximum of 0.5 mol/mol AGU (or anhydromonosaccharide unit), of the at least one sulfating agent.
- a further preferred variant of the method according to the invention is characterized in that in step b) first the at least one sulfating agent and the at least one acetylating agent are added to the mixture and then the at least one peroxodisulfate is added to the mixture.
- a further preferred variant of the method according to the invention is characterized in that the heat treatment in step b) is carried out at a temperature in the range from -10° C. to 150° C., preferably from 30° C. to 100° C., particularly preferably from 45° C to 80 °C, and/or for a period of 1 min to 10 h, preferably from 30 min to 20 h, particularly preferably from 3 h to 10 h.
- the at least one polysaccharide acetate sulfate is separated from the mixture in step c) in that the at least one polysaccharide acetate sulfate is precipitated by adding the mixture to a precipitation medium containing at least one alcohol and water and then by a mechanical Separation process, preferably by filtration, is separated.
- the at least one polysaccharide acetate sulfate is preferably washed once or several times with a washing solution after it has been separated off.
- a further preferred variant of the method according to the invention is characterized in that in step d) the at least one polysaccharide acetate sulphate is converted to the at least one polysaccharide sulphate by alkaline elimination of the acetate groups.
- the alkaline cleavage of the acetate groups is preferably achieved by adding an alkaline solution to the at least one polysaccharide acetate sulfate and leaving the resulting mixture for a period of 1 min to 30 h, preferably 1 h to 20 h, particularly preferably 5 h to 15 h, is stirred. It is preferred that after stirring, the mixture is neutralized and the at least one polysaccharide sulfate is separated, washed one or more times, and dried.
- the present invention also relates to a polysaccharide sulfate which can be produced or is produced using the method according to the invention.
- the polysaccharide sulfate according to the invention has a special regioselective distribution of substituents (within the individual AGU units or anhydromonosaccharide units), which distinguishes the polysaccharide sulfate according to the invention from already known polysaccharide sulfates.
- the exact distribution of substituents also depends to a certain extent on the particular polysaccharide used in the preparation, so that no general distribution of substituents is given can, which applies to all polysaccharide sulfates.
- the erfindungsge Permitted polysaccharide sulfate is characterized by the manufacturing process.
- the degree of substitution indicates how many OH groups are substituted in the sugar unit (or anhydromonosaccharide unit).
- the DS value for S OH groups in the glucose unit can be S at most.
- the degree of substitution is given as a sum parameter, such as when determining heteroatoms such as sulfur and nitrogen by elemental analysis.
- certain spectroscopic methods such as 13 C-NMR spectroscopy, it may be possible to assign the regioselectivity in the structural unit. In this way it is possible to determine the substitution in positions C6, C2 and CB.
- the degrees of substitution of the individual C positions can be determined by means of 13 C NMR spectroscopy.
- the NMR spectrum can be measured here, for example, in DO at 60 °C.
- the substitution can be quantified by integrating the signals from the 13 C-NMR spectrum and normalizing them to a signal from a carbon atom, eg CI.
- a preferred embodiment of the polysaccharide sulfate according to the invention is characterized in that the polysaccharide sulfate has a solution viscosity of at least 0.5 mm 2 /s, preferably at least 2 mm 2 /s, in a 1% solution in water, and/or a ( Overall) degree of substitution DS in a range from 0.15 to 1.8, preferably from 0.5 to 1.3 (determined, for example, via the sulfur content of the polysaccharide sulfate determined by means of elemental analysis or via 13 C-NMR spectroscopy). .
- the solution viscosity can be determined, for example, using DIN 51562-1:1999-01.
- the degree of substitution DS or total degree of substitution DS indicates the proportion of the C positions where substitution (a hydroxyl group by a sulfate group) can take place, i.e. where there is a hydroxyl group in the original polysaccharide, actually a substitution (the original hydroxyl group by a sulfate group) has taken place.
- the (overall) degree of substitution DS can have a value in the range from 0 to z, where z corresponds to the number of C-positions in the anhydroglucose unit of the polysaccharide at which substitution (a hydroxyl group by a sulfate group) can take place, ie where there is a hydroxyl group in the original polysaccharide.
- the anhydroglucose unit of cellulose contains three C-positions at which substitution (a hydroxyl group by a sulfate group) can take place, namely the C2-position, the CB-position and the C6-position. Consequently, in the case of cellulose sulfate, the (overall) degree of substitution DS can assume a value in the range from 0 to 3, with a minimum value of 0 having no substitution at any position and a maximum value of at every C2, C3 and C6 position im Polysaccharide a Substitu tion has taken place.
- a value of 1.5 for the (total) degree of substitution DS of cellulose sulfate would mean that 50% or half of all possible substitution positions (ie the sum of all C2, C3 and C6 Positions) of the polysaccharide sulfate substitution (of the original hydroxyl group by a sulfate group) has taken place.
- the (overall) degree of substitution DS does not allow a direct conclusion to be drawn as to how high the degree of substitution is at the individual C positions.
- a value of 1.5 for the (overall) degree of substitution DS of cellulose sulfate means that there is substitution (of a hydroxyl group by a sulfate group) at all C6 positions, at half of the C2 positions and at no C3 position ) has taken place.
- a value of 1.5 for the (overall) degree of substitution DS of cellulose sulfate could mean, for example, that there is a substitution ( a hydroxyl group through a sulfate group) has taken place.
- the degree of substitution DS or total degree of substitution DS can be determined via the sulfur content of the polysaccharide sulfate, it being possible for the sulfur content of the polysaccharide sulfate to be determined by means of elemental analysis.
- the degree of substitution can be determined via the sulfur content using the following formula (A):
- Formula (A) DS (M PS x S [%]) / (100 x M s - DM x S [%])
- Ms is the molar mass of the element to be determined, in this case sulfur
- MPS is the molar mass Mass of the polysaccharide used is
- DM is the difference between the molar mass of the new substituent (e.g. SO 3 ) and the leaving group (e.g. H).
- the degree of substitution DS or the total degree of substitution DS can also be determined by means of 13 C-NMR spectroscopy.
- the NMR spectrum can be measured in D2O at 60° C., for example.
- the degree of substitution from the 13 C-NMR spectrum can then be determined by integrating the signals from the 13 C-NMR spectrum and normalizing them to a signal from a carbon atom, for example CI (see, for example, Zhang et al., Polymer , 52 (1), pp. 26-32).
- 13 C-NMR spectroscopy can also be used in particular to determine the substitution on the individual carbon atoms in the AGU (or the anhydromonosaccharide unit).
- polysaccharide sulfate according to the invention is characterized in that the polysaccharide sulfate has a degree of substitution DS2 of at least 0.2, preferably at least 0.3, particularly preferably at least 0.4, at the C2 position and/or at the C6 position DS ⁇ a degree of substitution of at most 0.9, preferably at most 0.8, more preferably at most 0.7, most preferably at most 0.6.
- the degree of substitution of the individual C-positions can be determined by means of 13 C-NMR spectroscopy.
- the NMR spectrum can be measured in D2O at 60° C., for example.
- the individual degrees of substitution from the 13 C-NMR spectrum can then be determined by integrating the signals from the 13 C-NMR spectrum and normalizing them to a signal from a carbon atom, e.g. CI (see, e.g., Zhang et al., Polymer, 52 (1), pp. 26-32).
- a very particularly preferred embodiment of the polysaccharide sulfate according to the invention is characterized in that the polysaccharide sulfate is cellulose sulfate, the cellulose sulfate having a degree of substitution DS2 of at least 0.2, preferably at least 0.3, particularly preferably at least, at the C2 position 0.4, and/or a degree of substitution DS ⁇ at the C6 position of at most 0.9, preferably at most 0.8, particularly preferably at most 0.7, very particularly preferably at most 0.6.
- the present invention also relates to a polysaccharide sulfate (preferably cellulose sulfate) which has a degree of substitution DS2 of at least 0.2, preferably at least 0.3, particularly preferably at least 0.4, at the C2 position and/or one at the C6 position Degree of substitution DS 6 of at most 0.9, preferably at most 0.8, particularly preferably at most 0.7, very particularly preferably at most 0.6.
- a polysaccharide sulfate preferably cellulose sulfate
- degree of substitution DS2 of at least 0.2, preferably at least 0.3, particularly preferably at least 0.4, at the C2 position and/or one at the C6 position
- Degree of substitution DS 6 of at most 0.9, preferably at most 0.8, particularly preferably at most 0.7, very particularly preferably at most 0.6.
- the present invention relates to a method for producing microcapsules, in which at least one polysaccharide sulfate is produced using the method according to the invention for producing polysaccharide sulfates, or at least one polysaccharide sulfate according to the invention is provided, and then e) an aqueous solution of the at least one polysaccharide sulfate is produced f) at least one material to be encapsulated is added to the aqueous solution of at least one polysaccharide sulfate, resulting in a suspension, g) at least part of the suspension is dripped, resulting in droplets of the suspension, and h) the droplets of the suspension are dropped into a solution of at least one cationic polymer, the cationic polymer forming a polyelectrolyte complex with the polysaccharide sulfate and thereby the trop be converted into micro capsules in which the material to be encapsulated is encapsulated.
- a preferred variant of the method according to the invention for the production of microcapsules is characterized in that in the method a) a mixture comprising at least one polysaccharide and at least one polar aprotic solvent is prepared, b) the at least one polysaccharide is converted into at least one polysaccharide ridacetatsulfat by at least a sulphating agent, at least one acetylating agent and at least one peroxodisulphate are added to the mixture and the mixture is then subjected to a temperature treatment, c) the at least one polysaccharide acetate sulphate is separated from the mixture, d) the at least one polysaccharide acetate sulphate is converted into at least one polysaccharide sulphate e ) an aqueous solution of at least one polysaccharide sulfate is produced, f) at least one material to be encapsulated is added to the aqueous solution of at least one polysaccharide
- a further preferred variant of the method according to the invention is characterized in that the aqueous solution of the at least one polysaccharide sulfate produced in step e) is a 0.5% to 10% solution of the at least one polysaccharide sulfate in water, and/or the at least one material to be encapsulated is a material of biological origin or a material of non-biological origin, and/or in step f) additionally one or more substances selected from the group consisting of carrier materials; additives; solvents, e.g., DMSO; preservatives; Salt; glycerin; and mixtures thereof are added to the aqueous solution of the at least one polysaccharide, and/or the at least one cationic polymer is selected from the group consisting of polyethylenediamine, polypiperazine, polyarginine, polytriethylamine, spermine, polydimethylallylammonium, polydiallyldimethylammonium, polyvinylbenzyltri
- the at least one material to be encapsulated can be at least one material of biological origin.
- the at least one material to be encapsulated can also be at least one material of non-biological origin.
- the at least one material to be encapsulated can be at least one active pharmaceutical ingredient.
- the at least one material to be encapsulated can be at least one substance that is used as a medicinal substance.
- the pharmaceutical see active ingredient or drug can be encapsulated in the microcapsule implanted or injected.
- the at least one material to be encapsulated can also be at least one substance that is neither a pharmaceutical nor a drug.
- the present invention also relates to a microcapsule comprising at least one encapsulated material and a shell surrounding the at least one encapsulated material, the shell containing a polyelectrolyte complex of at least one cationic polymer and at least one polysaccharide sulfate according to the invention.
- microcapsule according to the invention can preferably be produced or produced using the method according to the invention for the production of microcapsules.
- the microcapsule according to the invention preferably has a diameter of from 0.1 ⁇ m to 1,000,000 ⁇ m, particularly preferably from 1 ⁇ m to 10,000 ⁇ m, very particularly preferably from 10 ⁇ m to 1000 ⁇ m.
- the present invention also relates to a microcapsule according to the invention for use as a medicine, for use in a method for implantation or for use in a method for injection.
- the present invention relates to the use of the microcapsule according to the invention as a medicament, in a method for implantation or in a method for injection.
- the sulfation was started by adding 4 mL chlorosulfonic acid (1 mol/mol AGU)+70 mL acetic anhydride (12 mol/mol AGU) in 80 mL DMF. A suspension of 8.3 g KSO (0.5 mol/mol AGU) in 50 mL DMF is then added. The synthesis took place at a temperature of 65 °C. After 1-2 hours the polymer will dissolve in the solvent.
- the polymer or the precipitated product was then stirred in an alkaline solution (8 g NaOH, 16 g, 60.200 ml ethanol) for 12 h to split off the acetate groups. After neutralization with ethanolic acetic acid (pH value adjustment between 6 and 9), three washes each in 300 mL ethanol followed and the washed product was dried in a vacuum drying cabinet.
- an alkaline solution 8 g NaOH, 16 g, 60.200 ml ethanol
- the cellulose sulfate produced in this way has a total degree of substitution DS of 0.8 (determined via the sulfur content of the cellulose sulfate determined by elemental analysis using formula (A)) and a viscosity of 14 mm 2 /s (determined according to DIN 51562-1 :1999-01) on. Further properties of the cellulose sulfate produced can be found in Table 1.
- the produced Cellulose sulfate has a degree of substitution DS of 0.30 at the C2 position and a degree of substitution DS 6 of 0.49 at the C6 position.
- the determination was made by integrating the signals from the 13 C-NMR spectrum and normalizing to a signal from a carbon atom, eg CI (see, for example, Zhang et al., Polymer, 52 (1), pp. 26-32).
- the 13 C-NMR spectrum thus gives a (total) degree of substitution DS of 0.79, which agrees with the (total) degree of substitution of 0.8 determined via the sulfur content within the scope of the rounding accuracy.
- the sulfation was started by adding 2 mL chlorosulfonic acid (0.5 mol/mol AGU) + 70 L mL acetic anhydride (12 mol/mol AGU) in 80 mL DMF. A suspension of 14 g (NFU SzOs (1 mol/mol AGU) in 50 mL DMF is then added. The synthesis took place at a temperature of 75° C. After approx. 1-2 hours, the polymer dissolves in the solvent.
- the cellulose sulfate produced in this way has a total degree of substitution DS of 1.2 (determined via the sulfur content of the cellulose sulfate determined by elemental analysis using formula (A)) and a viscosity of 2 mm 2 /s (determined according to DIN 51562-1 :1999-01) on. Further properties of the cellulose sulfate produced can be found in Table 1.
- MKC microcrystalline cellulose
- the sulfation was started by adding 2.5 g sulfuric acid trioxide-pyridine complex (0.5 mol/mol AGU)+70 mL acetic anhydride (12 mol/mol AGU) dissolved in 50 mL DMF. The synthesis took place at a temperature of 60 °C. Then a suspension of 14 g (NFU SzOs (4 mol/mol AGU) in 50 mL DMF is added. After about 1-2 hours, the polymer dissolves in the solvent.
- the cellulose sulfate produced in this way has a total degree of substitution DS of 0.85 (determined via the sulfur content of the cellulose sulfate determined by elemental analysis using formula (A)) and a viscosity of 1 mm 2 /s (determined according to DIN 51562-1 :1999-01) on. Further properties of the cellulose sulfate produced can be found in Table 1.
- Example 4
- the sulfation was started by adding 1.2 ml sulfuric acid (0.7 mol/mol AGU)+70 ml acetic anhydride (12 mol/mol AGU) in 80 ml DMF. Then a suspension of 8.3 g K2S2O8 (0.5 mol/mol AGU) in 50 mL DMF is added. The synthesis took place at a temperature of 50 °C. After about 1-2 hours the polymer dissolves in the solvent
- the cellulose sulfate produced in this way has a total degree of substitution DS of 1.0 (determined via the sulfur content of the cellulose sulfate determined by elemental analysis using formula (A)) and a viscosity of 10 mm 2 /s (determined according to DIN 51562-1 :1999-01) on. Further properties of the cellulose sulfate produced can be found in Table 1.
- the sulfation was started by adding 2 mL chlorosulfonic acid (0.5 mol/mol AGU)+70 mL acetic anhydride (12 mol/mol AGU) in 80 mL DMF. A suspension of 14 g (NH 4 ) 2 S 2 0s (4 mol/mol AGU) in 50 mL DMF is then added. The synthesis took place at a temperature of 75 °C. After about 1-2 hours, the polymer dissolves in the solvent.
- the cellulose sulfate produced in this way has a total degree of substitution DS of 1.3 (determined via the sulfur content of the cellulose sulfate determined by elemental analysis using formula (A)) and a viscosity of 22 mm 2 /s (determined according to DIN 51562-1 :1999-01) on. Further properties of the cellulose sulfate produced can be found in Table 1.
- the sulfation was started by adding 1.2 mL chlorosulfonic acid (0.5 mol/mol AGU)+70 mL acetic anhydride (12 mol/mol AGU) in 80 mL DMF. Then a suspension of 5.4 g K2S2O8 (0.5 mol/mol AGU) in 50 mL DMF is added. The synthesis took place at a temperature of 55.degree. After about 1-2 hours the polymer dissolves in the solvent.
- the arabinoxylan sulfate produced in this way has a total degree of substitution DS of 0.9 (determined via the sulfur content of the arabinoxylan sulfate determined by elemental analysis using formula (A)) and a viscosity of 2 mm 2 /s (determined according to DIN 51562-1 :1999-01) on.
- Table 1 shows other properties of the arabinoxylan sulfate produced.
- Table 1 Properties of the polysaccharide sulfates produced according to Examples 1 to 6 (viscosity and turbidity were measured in 1% (w/w) solutions).
- the (overall) degrees of substitution DS s in Table 1 were determined via the sulfur content of the cellulose sulfate determined by means of elemental analysis using formula (A).
- the (overall) degrees of substitution DS NMR in Table 1 were determined by means of 13 C-NMR spectroscopy (ie by integrating the signals from the 13 C-NMR spectrum and normalizing to a signal of a carbon atom, eg CI; see eg Zhang et al., Polymer, 52 (1), pp. 26-32).
- the viscosity values in Table 1 were determined according to DIN 51562-1:1999-01.
- the values for the turbidity in Table 1 were determined using DIN EN ISO 7027-1:2016-11.
- aqueous solution (1% w/w) is produced from the cellulose sulphate produced in exemplary embodiment 1 by appropriate weighing. After the substance has completely dissolved, a material to be encapsulated is rial added to the aqueous solution of at least one polysaccharide sulfate, resulting in a suspension. The cellulose sulfate solution is then added dropwise to a 1% commercially available polydiallyldimethylammonium chloride solution (polyDADMAC solution). Homogeneous round spherical particles (microcapsules) are obtained. The material to be encapsulated is encapsulated in the microcapsules obtained. The capsules obtained are shown in the photographs in Fig. 5 and Fig. 4.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Polymers & Plastics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2021/066640 WO2022262996A1 (de) | 2021-06-18 | 2021-06-18 | Verfahren zur herstellung von polysaccharidsulfaten und polysaccharidsulfat |
KR1020237041696A KR20240023510A (ko) | 2021-06-18 | 2021-06-18 | 다당류 설페이트의 제조 방법, 및 다당류 설페이트 |
CA3220442A CA3220442A1 (en) | 2021-06-18 | 2021-06-18 | Process for preparing polysaccharide sulfates, and polysaccharide sulfate |
BR112023026445A BR112023026445A2 (pt) | 2021-06-18 | 2021-06-18 | Processo para preparar sulfatos de polissacarídeo e sulfato de polissacarídeo |
JP2023577903A JP2024522789A (ja) | 2021-06-18 | 2021-06-18 | 硫酸化多糖を調製するための方法、および硫酸化多糖 |
CN202180099505.6A CN117500839A (zh) | 2021-06-18 | 2021-06-18 | 用于制备硫酸多糖的方法及硫酸多糖 |
US18/570,416 US20240287209A1 (en) | 2021-06-18 | 2021-06-18 | Process for preparing polysaccharide sulfates, and polysaccharide sulfate |
AU2021450924A AU2021450924A1 (en) | 2021-06-18 | 2021-06-18 | Process for preparing polysaccharide sulfates, and polysaccharide sulfate |
EP21735236.8A EP4355790A1 (de) | 2021-06-18 | 2021-06-18 | Verfahren zur herstellung von polysaccharidsulfaten und polysaccharidsulfat |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2021/066640 WO2022262996A1 (de) | 2021-06-18 | 2021-06-18 | Verfahren zur herstellung von polysaccharidsulfaten und polysaccharidsulfat |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022262996A1 true WO2022262996A1 (de) | 2022-12-22 |
Family
ID=76641681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2021/066640 WO2022262996A1 (de) | 2021-06-18 | 2021-06-18 | Verfahren zur herstellung von polysaccharidsulfaten und polysaccharidsulfat |
Country Status (9)
Country | Link |
---|---|
US (1) | US20240287209A1 (de) |
EP (1) | EP4355790A1 (de) |
JP (1) | JP2024522789A (de) |
KR (1) | KR20240023510A (de) |
CN (1) | CN117500839A (de) |
AU (1) | AU2021450924A1 (de) |
BR (1) | BR112023026445A2 (de) |
CA (1) | CA3220442A1 (de) |
WO (1) | WO2022262996A1 (de) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2539451A (en) | 1948-02-27 | 1951-01-30 | Eastman Kodak Co | Method of preparing sulfuric acid esters of cellulose |
US2683143A (en) | 1951-08-02 | 1954-07-06 | Celanese Corp | Process for the production of lower aliphatic acid esters of cellulose containing a morpholine substituent |
US2969355A (en) | 1958-05-15 | 1961-01-24 | Eastman Kodak Co | Method of preparing cellulose sulfate |
DE4019116A1 (de) | 1989-06-13 | 1990-12-20 | Akad Wissenschaften Ddr | Verfahren zur herstellung von wasserloeslichem cellulosesulfat |
DE4021049A1 (de) | 1990-06-29 | 1992-01-02 | Akad Wissenschaften Ddr | Verfahren zur herstellung wasserloeslicher cellulosesulfate mit hoher loesungsviskositaet |
DE4435180C1 (de) | 1994-09-30 | 1996-05-09 | Fraunhofer Ges Forschung | Verfahren zur Herstellung teilsubstituierter, löslicher Cellulosesulfate und deren Verwendung |
EP1863851A1 (de) | 2005-03-11 | 2007-12-12 | Austrianova Biotechnology GmbH | Verfahren zur herstellung von cellulosesulfat mit verbesserten eigenschaften |
DE102007035322A1 (de) | 2007-07-25 | 2009-01-29 | Friedrich-Schiller-Universität Jena | Verfahren zur Herstellung wasserlöslicher, niedrig substituierter Cellulosesulfate |
DE102013204817A1 (de) * | 2013-03-19 | 2014-09-25 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zur Herstellung von sulfatierten Celluloseestern sowie hieraus hergestellte Mikrokapseln und deren Verwendung |
-
2021
- 2021-06-18 AU AU2021450924A patent/AU2021450924A1/en active Pending
- 2021-06-18 JP JP2023577903A patent/JP2024522789A/ja active Pending
- 2021-06-18 CN CN202180099505.6A patent/CN117500839A/zh active Pending
- 2021-06-18 BR BR112023026445A patent/BR112023026445A2/pt unknown
- 2021-06-18 WO PCT/EP2021/066640 patent/WO2022262996A1/de active Application Filing
- 2021-06-18 EP EP21735236.8A patent/EP4355790A1/de active Pending
- 2021-06-18 US US18/570,416 patent/US20240287209A1/en active Pending
- 2021-06-18 CA CA3220442A patent/CA3220442A1/en active Pending
- 2021-06-18 KR KR1020237041696A patent/KR20240023510A/ko active Search and Examination
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2539451A (en) | 1948-02-27 | 1951-01-30 | Eastman Kodak Co | Method of preparing sulfuric acid esters of cellulose |
US2683143A (en) | 1951-08-02 | 1954-07-06 | Celanese Corp | Process for the production of lower aliphatic acid esters of cellulose containing a morpholine substituent |
US2969355A (en) | 1958-05-15 | 1961-01-24 | Eastman Kodak Co | Method of preparing cellulose sulfate |
DE4019116A1 (de) | 1989-06-13 | 1990-12-20 | Akad Wissenschaften Ddr | Verfahren zur herstellung von wasserloeslichem cellulosesulfat |
DE4021049A1 (de) | 1990-06-29 | 1992-01-02 | Akad Wissenschaften Ddr | Verfahren zur herstellung wasserloeslicher cellulosesulfate mit hoher loesungsviskositaet |
DE4435180C1 (de) | 1994-09-30 | 1996-05-09 | Fraunhofer Ges Forschung | Verfahren zur Herstellung teilsubstituierter, löslicher Cellulosesulfate und deren Verwendung |
EP1863851A1 (de) | 2005-03-11 | 2007-12-12 | Austrianova Biotechnology GmbH | Verfahren zur herstellung von cellulosesulfat mit verbesserten eigenschaften |
US20090011033A1 (en) * | 2005-03-11 | 2009-01-08 | Austrianova Biotechnology Gmbh | Process for the manufacture of cellulose sulfate with improved characteristics |
DE102007035322A1 (de) | 2007-07-25 | 2009-01-29 | Friedrich-Schiller-Universität Jena | Verfahren zur Herstellung wasserlöslicher, niedrig substituierter Cellulosesulfate |
DE102013204817A1 (de) * | 2013-03-19 | 2014-09-25 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verfahren zur Herstellung von sulfatierten Celluloseestern sowie hieraus hergestellte Mikrokapseln und deren Verwendung |
Non-Patent Citations (9)
Title |
---|
BOHLMANN ET AL., CHEMIE INGENIEUR TECHNIK, vol. 74, 2021, pages 359 - 363 |
G. CHAUVELON, CARBOHYDRATE RESEARCH, vol. 338, 2003, pages 743 - 750 |
HETTRICH KAY ET AL: "New Possibilities of the Acetosulfation of Cellulose", MACROMOLECULAR SYMPOSIA, vol. 262, no. 1, 1 January 2008 (2008-01-01), DE, pages 162 - 169, XP055899113, ISSN: 1022-1360, DOI: 10.1002/masy.200850216 * |
LUKANOFF, B.DAUTZENBERG, H., DAS PAPIER, vol. 6, 1994, pages 287 - 298 |
MUHITDINOV BAHTIYOR ET AL: "Homogenous synthesis of sodium cellulose sulfates with regulable low and high degree of substitutions with SO3/Py in N,N-dimethylacetamide/LiCl", EUROPEAN POLYMER JOURNAL, PERGAMON PRESS LTD OXFORD, GB, vol. 119, 23 July 2019 (2019-07-23), pages 181 - 188, XP085817208, ISSN: 0014-3057, [retrieved on 20190723], DOI: 10.1016/J.EURPOLYMJ.2019.07.030 * |
ROHOWSKY ET AL., CARBOHYDR. POLYMERS, vol. 142, 2016, pages 56 - 62 |
WAGENKNECHT ET AL., DAS PAPIER, vol. 50, no. 12, 1996, pages 712 - 720 |
ZHANG ET AL., POLYMER, vol. 52, no. 1, pages 26 - 32 |
ZHANG ET AL.: "Synthesis and spectroscopic analysis of cellulose sulfates with regulable total degrees of substitution and sulfation patterns via 13C NMR and FT Raman spectroscopy", POLYMER, vol. 52, no. 1, pages 26 - 32, XP027568562 |
Also Published As
Publication number | Publication date |
---|---|
CA3220442A1 (en) | 2022-12-22 |
EP4355790A1 (de) | 2024-04-24 |
BR112023026445A2 (pt) | 2024-03-05 |
CN117500839A (zh) | 2024-02-02 |
KR20240023510A (ko) | 2024-02-22 |
AU2021450924A1 (en) | 2023-11-30 |
US20240287209A1 (en) | 2024-08-29 |
JP2024522789A (ja) | 2024-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE68917009T2 (de) | Sulfaminoderivate von Chondroitinsulfat, Dermatansulfat und Hyaluronsäure und ihre pharmakologischen Eigenschaften. | |
DE3645226C2 (de) | ||
DE3008413C2 (de) | Verfahren zur Herstellung von Äthylcarboxymethylcellulose | |
WO1996030411A1 (de) | Verfahren zur aktivierung von polysacchariden, danach hergestellte polysaccharide und deren verwendung | |
WO2019002095A1 (de) | Hydrogel-bildende mehrkomponentenfaser | |
DE19746264A1 (de) | Verfahren zur Herstellung einer Carboxymethylcellulose mit verbesserter Wasserretention | |
DE1468017B2 (de) | Hydroxypropylcellulose und Verfahren zur deren Herstellung | |
EP0678525B1 (de) | Teilweise acylierte beta-Cyclodextrine | |
DE69220664T2 (de) | Kationische polysaccharide | |
EP0860522B1 (de) | Verfahren zur Herstellung von Formkörpern aus Polysaccharidmischungen | |
EP4355790A1 (de) | Verfahren zur herstellung von polysaccharidsulfaten und polysaccharidsulfat | |
WO1999054361A1 (de) | Verfahren zur aktivierung und derivatisierung von cellulose | |
DD212969A1 (de) | Verfahren zur modifizierung von carboxymethylcellulose | |
EP0873364B1 (de) | Verfahren zur herstellung von cellulosederivaten | |
DE1668542A1 (de) | Verfahren zur Herstellung der Schwefelsaeureester von Zellulose und Staerke | |
DE102013204817B4 (de) | Verfahren zur Herstellung von sulfatierten Celluloseethern sowie deren Verwendung zur Herstellung von Mikrokapseln | |
WO2001007485A1 (de) | Verfahren zur gezielten depolymerisation von polysacchariden | |
EP0572910B1 (de) | Dialysemembran aus Polysaccharidether II | |
DE2530451A1 (de) | Ester von polyhydroxypolymeren und verfahren zu ihrer herstellung | |
DE1493247A1 (de) | Verfahren zur Herstellung wasserloeslicher Celluloseaether | |
DD299313A5 (de) | Verfahren zur herstellung von wasserloeslichen sulfaten der cellulose und verwandter polysaccharide | |
EP1574522B1 (de) | Verfahren zur Herstellung von quellfähigen modifizierten Cellulose-oder Stärkeethern | |
DE1493247C (de) | Verfahren zur Herstellung von wasserlöslichen Cellulosemischäthern in zwei Stufen | |
DD233377A1 (de) | Verfahren zur herstellung von carboxymethylcellulose | |
WO2020119979A1 (de) | Xylan aufweisende zusammensetzung und verfahren zur herstellung einer xylan aufweisenden zusammensetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21735236 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 3220442 Country of ref document: CA Ref document number: 2021450924 Country of ref document: AU Ref document number: AU2021450924 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202317079504 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 805964 Country of ref document: NZ |
|
ENP | Entry into the national phase |
Ref document number: 2021450924 Country of ref document: AU Date of ref document: 20210618 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 18570416 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12023553432 Country of ref document: PH Ref document number: 202180099505.6 Country of ref document: CN Ref document number: 2301008210 Country of ref document: TH |
|
ENP | Entry into the national phase |
Ref document number: 2023577903 Country of ref document: JP Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112023026445 Country of ref document: BR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2021735236 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2021735236 Country of ref document: EP Effective date: 20240118 |
|
ENP | Entry into the national phase |
Ref document number: 112023026445 Country of ref document: BR Kind code of ref document: A2 Effective date: 20231215 |